Boehringer Ingelheim Drug Patent Portfolio

Boehringer Ingelheim owns 26 orange book drugs protected by 186 US patents with Aggrenox having the least patent protection, holding only 1 patent. And Spiriva Respimat with maximum patent protection, holding 39 patents. Given below is the list of Boehringer Ingelheim's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Dec, 2034
Active
US9949997 Pharmaceutical composition, methods for treating and uses thereof 17 Nov, 2034
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
Active
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Jun, 2034
Active
US9949997 Pharmaceutical composition, methods for treating and uses thereof 17 May, 2034
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
Active
US11666590 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
Active
US11813275 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
Active
US9555001 Pharmaceutical composition and uses thereof 06 Sep, 2033
Active
US9555001 Pharmaceutical composition and uses thereof 06 Mar, 2033
Active
US10596120 Pharmaceutical compositions 07 Sep, 2032
Active
US10596120 Pharmaceutical compositions 07 Mar, 2032
Active
US11564886 Pharmaceutical compositions 07 Mar, 2032
Active
US8853156 Treatment for diabetes in patients inappropriate for metformin therapy 05 Sep, 2031
Active
US9034822 Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 20 Jul, 2031
Active
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Apr, 2031
Active
US10610489 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof 30 Mar, 2031
Active
US8853156 Treatment for diabetes in patients inappropriate for metformin therapy 05 Mar, 2031
Active
US9034822 Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 20 Jan, 2031
Active
US10004743 Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient 05 Jan, 2031
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Dec, 2030
Active
US9155705 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 Nov, 2030
Active
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Oct, 2030
Active
US10610489 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof 30 Sep, 2030
Active
US10004743 Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient 05 Jul, 2030
Active
US8545884 Solid pharmaceutical formulations comprising BIBW 2992 19 Jun, 2030
Active
US10406172 Pharmaceutical composition, methods for treating and uses thereof 15 Jun, 2030
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Jun, 2030
Active
US9155705 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 May, 2030
Active
US9010323 Inhaler and sieve for an inhaler 19 Apr, 2030
Active
US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Apr, 2030
Active
US8426586 Process for preparing amino crotonyl compounds 10 Apr, 2030
Active
US11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug 10 Apr, 2030
Active
US10034877 Treatment for diabetes in patients inappropriate for metformin therapy 05 Feb, 2030
Active
US9486526 Treatment for diabetes in patients inappropriate for metformin therapy 05 Feb, 2030
Active
US8474447 Inhaler device 17 Jan, 2030
Active
US8545884 Solid pharmaceutical formulations comprising BIBW 2992 19 Dec, 2029
Active
US9907756 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative 07 Dec, 2029
Active
US10105323 Pharmaceutical dosage form for immediate release of an indolinone derivative 04 Dec, 2029
Active
US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Oct, 2029
Active
US8426586 Process for preparing amino crotonyl compounds 10 Oct, 2029
Active
US10022379 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
Active
US10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
Active
US9415016 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
Active
US8679533 Pramipexole once-daily dosage form 08 Sep, 2029
Active
US10034877 Treatment for diabetes in patients inappropriate for metformin therapy 05 Aug, 2029
Active
US9486526 Treatment for diabetes in patients inappropriate for metformin therapy 05 Aug, 2029
Active
US9907756 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative 07 Jun, 2029
Active
US10105323 Pharmaceutical dosage form for immediate release of an indolinone derivative 04 Jun, 2029
Active
US10022379 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
Active
US10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
Active
US9415016 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
Active
US8460704 Extended release formulation of nevirapine 12 Mar, 2029
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
Active
US7837235 Device for clamping a fluidic component 13 Sep, 2028
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
Active
US7695734 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof 26 Apr, 2028
Active
US7837235 Device for clamping a fluidic component 13 Mar, 2028
Active
US7866474 Film container 02 Mar, 2028
Active
US11033552 DPP IV inhibitor formulations 04 Nov, 2027
Active
US8673927 Uses of DPP-IV inhibitors 04 Nov, 2027
Active
US9173859 Uses of DPP IV inhibitors 04 Nov, 2027
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
Active
US9027967 Device for clamping a fluidic component 01 Oct, 2027
Active
US7694676 Dry powder inhaler 12 Sep, 2027
Active
US7866474 Film container 31 Aug, 2027
Active
US9539258 Quinazoline derivatives for the treatment of cancer diseases 09 May, 2027
Active
US11033552 DPP IV inhibitor formulations 04 May, 2027
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Apr, 2027
Active
US9027967 Device for clamping a fluidic component 31 Mar, 2027
Active
US7694676 Dry powder inhaler 12 Mar, 2027
Active
US7727984 Medicaments for the treatment of chronic obstructive pulmonary disease 19 Jan, 2027
Active
US9539258 Quinazoline derivatives for the treatment of cancer diseases 09 Nov, 2026
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Oct, 2026
Active
US8022082 Method for the administration of an anticholinergic by inhalation 19 Jul, 2026
Active
USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them 13 Jul, 2026
Active
US10154990 Medicaments for the treatment or prevention of fibrotic diseases 08 Jul, 2026
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
Active
US6762180 Substituted indolines which inhibit receptor tyrosine kinases 01 Apr, 2026
Active
US7932273 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament 07 Mar, 2026
Active
US8022082 Method for the administration of an anticholinergic by inhalation 19 Jan, 2026
Active
USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them 13 Jan, 2026
Active
US10154990 Medicaments for the treatment or prevention of fibrotic diseases 08 Jan, 2026
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 Nov, 2025
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
Active
US6762180 Substituted indolines which inhibit receptor tyrosine kinases 01 Oct, 2025
Active
US7932273 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament 07 Sep, 2025
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 May, 2025
Active
US7220742 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
Active
US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Feb, 2025
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Aug, 2024 Expired
US7989474 Use of Lck inhibitors for treatment of immunologic diseases 06 Apr, 2024 Expired
US7119093 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition 21 Feb, 2024 Expired
US9925174 Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof 14 Dec, 2023 Expired
US7056916 Medicaments for the treatment of chronic obstructive pulmonary disease 07 Dec, 2023 Expired
US7491719 Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments 10 Nov, 2023 Expired
US7786111 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023 Expired
US8044046 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023 Expired
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023 Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023 Expired
US9925174 Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof 14 Jun, 2023 Expired
US8003679 Use of inhibitors of the renin-angiotensin system 06 Oct, 2022 Expired
US7070800 Inhalable powder containing tiotropium 22 Jul, 2022 Expired
US6087380 Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions 28 Jun, 2022 Expired
USRE38912 Process for preparing powder formulations 11 Apr, 2022 Expired
US6777423 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Mar, 2022 Expired
US6908928 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Mar, 2022 Expired
US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Mar, 2022 Expired
US7642268 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Mar, 2022 Expired
US7988001 Container provided with a pressure equalization opening 04 Feb, 2022 Expired
US7070800 Inhalable powder containing tiotropium 22 Jan, 2022 Expired
US6087380 Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions 28 Dec, 2021 Expired
USRE38912 Process for preparing powder formulations 11 Oct, 2021 Expired
US6777423 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Sep, 2021 Expired
US6908928 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Sep, 2021 Expired
US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Sep, 2021 Expired
US7642268 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Sep, 2021 Expired
US7988001 Container provided with a pressure equalization opening 04 Aug, 2021 Expired
US6988496 Cartridge for a liquid 23 Aug, 2020 Expired
US6488962 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms 20 Jun, 2020 Expired
US7998953 Use of inhibitors of the renin-angiotensin system 06 Jun, 2020 Expired
US6739333 Stainless steel canister for propellant-driven metering aerosols 26 May, 2020 Expired
US6983743 Stainless steel canister for propellant-driven metering aerosols 26 May, 2020 Expired
US6147095 Method for improving the pharmacokinetics of tipranavir 29 Apr, 2020 Expired
US6988496 Cartridge for a liquid 23 Feb, 2020 Expired
US6358986 Polymorphs of telmisartan 10 Jan, 2020 Expired
US5852195 Pyranone compounds useful to treat retroviral infections 22 Dec, 2019 Expired
US6147095 Method for improving the pharmacokinetics of tipranavir 29 Oct, 2019 Expired
US7802568 Cartridge for a liquid 26 Aug, 2019 Expired
US5852195 Pyranone compounds useful to treat retroviral infections 22 Jun, 2019 Expired
US6846413 Microstructured filter 28 Feb, 2019 Expired
US6977042 Microstructured filter 28 Feb, 2019 Expired
US7802568 Cartridge for a liquid 26 Feb, 2019 Expired
US6890898 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019 Expired
US7078381 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019 Expired
US7459428 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019 Expired
US6231887 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation 27 Jan, 2019 Expired
US6846413 Microstructured filter 28 Aug, 2018 Expired
US6977042 Microstructured filter 28 Aug, 2018 Expired
USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jul, 2018 Expired
US6251912 Substituted quinazoline derivatives 29 Jul, 2018 Expired
US6231887 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation 27 Jul, 2018 Expired
USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jan, 2018 Expired
US6001861 Use of pramipexole in the treatment of restless legs syndrome 16 Jan, 2018 Expired
US6194445 Use of pramipexole in the treatment of restless legs syndrome 16 Jan, 2018 Expired
US6149054 Mechanical counter for a metering apparatus 19 Jun, 2017 Expired
US6453795 Locking mechanism for a spring-actuated device 05 Jun, 2017 Expired
US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals 24 Apr, 2017 Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Apr, 2017 Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Apr, 2017 Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Apr, 2017 Expired
US6015577 Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation 18 Jan, 2017 Expired
US6149054 Mechanical counter for a metering apparatus 19 Dec, 2016 Expired
US6453795 Locking mechanism for a spring-actuated device 05 Dec, 2016 Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 01 Dec, 2016 Expired
US7246615 Atomising nozzle and filter and spray generating device 01 Dec, 2016 Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Oct, 2016 Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 04 Oct, 2016 Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Oct, 2016 Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Oct, 2016 Expired
US6340475 Extending the duration of drug release within the stomach during the fed mode 19 Sep, 2016 Expired
US6635280 Extending the duration of drug release within the stomach during the fed mode 19 Sep, 2016 Expired
US7246615 Atomising nozzle and filter and spray generating device 31 May, 2016 Expired
US6176242 Method of treating manic depression by brain infusion 31 May, 2016 Expired
US5603918 Aerosol composition of a salt of ipratropium and a salt of albuterol 09 Jun, 2015 Expired
US6169181 Compounds useful to treat retroviral infections 06 Nov, 2014 Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014 Expired
US5676930 Stabilized medicinal aerosol solution formulations 14 Oct, 2014 Expired
US5662271 Atomizing devices and methods 02 Sep, 2014 Expired
US6169181 Compounds useful to treat retroviral infections 06 May, 2014 Expired
US5591762 Benzimidazoles useful as angiotensin-11 antagonists 07 Jan, 2014 Expired
US5472143 Atomising nozzle and filter and spray generation device 29 Sep, 2013 Expired
US5911851 Atomizing nozzle and filter and spray generating device 29 Sep, 2013 Expired
US6007676 Atomizing nozzle and filter and spray generating device 29 Sep, 2013 Expired
US6503362 Atomizing nozzle an filter and spray generating device 29 Sep, 2013 Expired
US5497944 Atomising devices and methods 12 Mar, 2013 Expired
US5478578 Powders for inhalation 26 Dec, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Boehringer Ingelheim.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 05 Jul, 2024 US9539258
Expire Patent 17 Jun, 2024 US8178541
Expire Patent 17 Jun, 2024 US8178541
Expire Patent 17 Jun, 2024 US8178541
Payment of Maintenance Fee, 8th Year, Large Entity 02 May, 2024 US9486526
Expire Patent 25 Mar, 2024 US8119648
Expire Patent 25 Mar, 2024 US8119648
Expire Patent 25 Mar, 2024 US8119648
Patent Issue Date Used in PTA Calculation 27 Feb, 2024 US11911388
Email Notification 27 Feb, 2024 US11911388
Email Notification 27 Feb, 2024 US11911388
Recordation of Patent Grant Mailed 27 Feb, 2024 US11911388
Recordation of Patent Grant Mailed 27 Feb, 2024 US11911388
Patent Issue Date Used in PTA Calculation 27 Feb, 2024 US11911388
Patent eGrant Notification 27 Feb, 2024 US11911388


Boehringer Ingelheim's Drug Patent Litigations

Boehringer Ingelheim's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Sep 26, 2011, against patent number US8679533. The petitioner , challenged the validity of this patent, with Ernest J. Lee et al as the respondent. Click below to track the latest information on how companies are challenging Boehringer Ingelheim's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8853156 August, 2016 Terminated
(01 Aug, 2017)
Boehringer Ingelheim Pharmaceuticals Inc. et al. Mylan Pharmaceuticals Inc. et al.
US8673927 August, 2016 Terminated
(18 Jul, 2017)
Boehringer Ingelheim Pharmaceuticals Inc. et al. Mylan Pharmaceuticals Inc. et al.
US8846695 August, 2016 Terminated
(18 Jul, 2017)
Boehringer Ingelheim Pharmaceuticals Inc. et al. Mylan Pharmaceuticals Inc. et al.
US9173859 August, 2016 Terminated-Denied
(03 Feb, 2017)
Boehringer Ingelheim Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.
US6340475 April, 2014 Final Written Decision
(21 Sep, 2015)
Depomed, Inc. Endo Pharmaceutical Inc. et al.
US6635280 April, 2014 Final Written Decision
(21 Sep, 2015)
Depomed, Inc. Endo Pharmaceutical Inc. et al.
US6340475 January, 2014 FWD Entered
(08 Jul, 2015)
Depomed, Inc. Purdue Pharma L.P.
US6635280 January, 2014 FWD Entered
(08 Jul, 2015)
DepoMed, Inc. Purdue Pharma L.P.
US6340475 April, 2014 Institution Denied
(29 Sep, 2014)
Depomed, Inc. Endo Pharmaceutical Inc. et al.
US6635280 April, 2014 Institution Denied
(29 Sep, 2014)
Depomed, Inc. Endo Pharmaceutical Inc. et al.
US8679533 September, 2011 Decision
(22 Oct, 2013)
Ernest J. Lee et al


Boehringer Ingelheim Drug Patents' Oppositions Filed in EPO

Boehringer Ingelheim drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Feb 06, 2006, by Speedel Pharma Ag. This opposition was filed on patent number EP98947698A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP11179908A Apr, 2023 Generics [UK] Limited Granted and Under Opposition
EP11179908A Apr, 2023 STADA Arzneimittel AG Granted and Under Opposition
EP11179908A Apr, 2023 Kraus & Weisert Patentanwälte PartGmbB Granted and Under Opposition
EP14715274A Apr, 2023 TEVA PHARMACEUTICAL INDUSTRIES, LTD. Granted and Under Opposition
EP11179908A Apr, 2023 ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Granted and Under Opposition
EP11179908A Apr, 2023 Sandoz AG Granted and Under Opposition
EP10703288A Jan, 2021 Generics (U.K.) Limited Granted and Under Opposition
EP10703288A Jan, 2021 STADA Arzneimittel AG Granted and Under Opposition
EP10703288A Dec, 2020 ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Granted and Under Opposition
EP11194615A Jun, 2020 ELKINGTON AND FIFE LLP Granted and Under Opposition
EP10730454A Dec, 2019 Generics [UK] Ltd Granted and Under Opposition
EP10730454A Dec, 2019 LEK Pharmaceuticals d.d. Granted and Under Opposition
EP10730454A Nov, 2019 Teva Pharmaceutical Industries Ltd Granted and Under Opposition
EP09757601A Aug, 2019 Teva Pharmaceutical Industries Ltd Granted and Under Opposition
EP09757601A Aug, 2019 Ter Meer Steinmeister & Partner Patentanwälte mbB Granted and Under Opposition
EP09757601A Aug, 2019 Generics (U.K.) Limited Granted and Under Opposition
EP14715578A Aug, 2019 Generics (U.K.) Limited Granted and Under Opposition
EP14715578A Aug, 2019 Teva Pharmaceutical Industries Ltd Granted and Under Opposition
EP14715578A Aug, 2019 ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Granted and Under Opposition
EP14715578A Aug, 2019 Gillard, Richard Edward Granted and Under Opposition
EP14715578A Aug, 2019 Stada-Arzneimittel Aktiengesellschaft Granted and Under Opposition
EP14715578A Aug, 2019 EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság Granted and Under Opposition
EP14715578A Aug, 2019 Alfred E. Tiefenbacher (GmbH & Co. KG) Granted and Under Opposition
EP14715578A Aug, 2019 KRKA, d.d., Novo mesto Granted and Under Opposition
EP09728065A Jun, 2019 isarpatent - Patent- und Rechtsanwälte Behnisch Barth Charles Hassa Peckmann und Partner mbB Revoked
EP09728065A Jun, 2019 Galenicum Health S.L.U. Revoked
EP09728065A Jun, 2019 Hexal AG Revoked
EP09728065A Jun, 2019 HGF Limited Revoked
EP09757593A Nov, 2018 Zentiva Group, a.s. Granted and Under Opposition
EP09757593A Nov, 2018 Generics (U.K.) Limited Granted and Under Opposition
EP09757593A Nov, 2018 Galenicum Health S.L. Granted and Under Opposition
EP09757593A Nov, 2018 Teva Pharmaceutical Industries Ltd Granted and Under Opposition
EP08787264A Jul, 2017 ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Granted and Under Opposition
EP08787264A Jul, 2017 STADA Arzneimittel AG Granted and Under Opposition
EP08787264A Jul, 2017 Hexal AG Granted and Under Opposition
EP08787264A Jul, 2017 Generics (U.K.) Limited Granted and Under Opposition
EP08756672A Dec, 2016 FRKelly Revoked
EP12155662A Sep, 2016 LEK Pharmaceuticals d.d. Patent maintained as amended
EP10175188A Dec, 2015 Generics (UK) Limited Revoked
EP10175188A Dec, 2015 Galenicum Health S.L. Revoked
EP10175188A Dec, 2015 Hexal AG Revoked
EP10175188A Dec, 2015 STADA Arzneimittel AG Revoked
EP10175188A Dec, 2015 Teva Pharmaceutical Industries LTD. Revoked
EP10175638A Jul, 2015 Generics [UK] Limited (trading as Mylan) Revoked
EP10175638A Jul, 2015 STADA Arzneimittel AG Revoked
EP10175638A Jul, 2015 Hexal AG Revoked
EP10175638A Jul, 2015 Teva Pharmaceutical Industries Ltd. Revoked
EP07728723A Jan, 2015 Hexal AG Revoked
EP03771959A Jun, 2014 Maiwald Patentanwalts GmbH Opposition rejected
EP03745781A May, 2014 Actavis Group PTC ehf Revoked
EP03745781A May, 2014 Vossius & Partner Revoked
EP03745781A May, 2014 Teva UK Limited Revoked
EP05737938A Apr, 2014 Aechter, Bernd Opposition rejected
EP03771959A Oct, 2013 Actavis Group PTC ehf Opposition rejected
EP05823930A Aug, 2013 SANDOZ AG Opposition rejected
EP03743368A Apr, 2013 Sanovel IIaç San. ve Tic. A.S. Patent maintained as amended
EP03743368A Mar, 2013 Stötter, Gerd Patent maintained as amended
EP07115663A Oct, 2012 Sanovel IIaç San. ve Tic. A.S. Revoked
EP07115663A Oct, 2012 Stötter, Gerd Revoked
EP05763065A Aug, 2012 Dr. May, Mark Andrew Patent maintained as amended
EP09153155A Jul, 2012 PONS PATENTES Y MARCAS INTERNACIONAL, S.L. Revoked
EP09153155A Jul, 2012 Sanovel Ilac Sanayii ve Ticaret A.S. Revoked
EP09153155A Jul, 2012 Stötter, Gerd Revoked
EP2004006768W Apr, 2012 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Revoked
EP05777774A Aug, 2011 Teva Pharmaceutical Industries LTD. Patent maintained as amended
EP05777774A Aug, 2011 Sölch, Günter Patent maintained as amended
EP04764411A Jan, 2010 APOTEX INC. Opposition rejected
EP04021889A Apr, 2008 Merck & Co., Inc. Revoked
EP04021889A Apr, 2008 Sanofi-Aventis Deutschland GmbH Revoked
EP04021889A Apr, 2008 TEVA PHARMACEUTICAL INDUSTRIES LTD. Revoked
EP04021889A Apr, 2008 LES LABORATOIRES SERVIER Revoked
EP01986599A Dec, 2006 AstraZeneca AB Patent maintained as amended
EP01986599A Dec, 2006 PFIZER LIMITED Patent maintained as amended
EP98947698A Feb, 2006 Speedel Pharma AG Patent maintained as amended


Boehringer Ingelheim's Family Patents

Boehringer Ingelheim drugs have patent protection in a total of 64 countries. It's US patent count contributes only to 11.4% of its total global patent coverage. 8 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Boehringer Ingelheim Drug List

Given below is the complete list of Boehringer Ingelheim's drugs and the patents protecting them.


1. Aggrenox

Aggrenox is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6015577 Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation 18 Jan, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aggrenox's drug page


2. Aptivus

Aptivus is protected by 8 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6147095
(Pediatric)
Method for improving the pharmacokinetics of tipranavir 29 Apr, 2020
(4 years ago)
Expired
US5852195
(Pediatric)
Pyranone compounds useful to treat retroviral infections 22 Dec, 2019
(4 years ago)
Expired
US6147095 Method for improving the pharmacokinetics of tipranavir 29 Oct, 2019
(4 years ago)
Expired
US5852195 Pyranone compounds useful to treat retroviral infections 22 Jun, 2019
(5 years ago)
Expired
US6231887
(Pediatric)
Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation 27 Jan, 2019
(5 years ago)
Expired
US6231887 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation 27 Jul, 2018
(6 years ago)
Expired
US6169181
(Pediatric)
Compounds useful to treat retroviral infections 06 Nov, 2014
(9 years ago)
Expired
US6169181 Compounds useful to treat retroviral infections 06 May, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aptivus's drug page


3. Atrovent Hfa

Atrovent Hfa is protected by 5 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8474447 Inhaler device 17 Jan, 2030
(5 years from now)
Active
US6739333 Stainless steel canister for propellant-driven metering aerosols 26 May, 2020
(4 years ago)
Expired
US6983743 Stainless steel canister for propellant-driven metering aerosols 26 May, 2020
(4 years ago)
Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014
(9 years ago)
Expired
US5676930 Stabilized medicinal aerosol solution formulations 14 Oct, 2014
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atrovent Hfa's drug page


4. Combivent

Combivent is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5603918 Aerosol composition of a salt of ipratropium and a salt of albuterol 09 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combivent's drug page


5. Combivent Respimat

Combivent Respimat is protected by 24 patents, out of which 19 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Oct, 2030
(6 years from now)
Active
US7837235 Device for clamping a fluidic component 13 Mar, 2028
(3 years from now)
Active
US9027967 Device for clamping a fluidic component 31 Mar, 2027
(2 years from now)
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Oct, 2026
(2 years from now)
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 May, 2025
(7 months from now)
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Aug, 2024
(a month ago)
Expired
US7988001 Container provided with a pressure equalization opening 04 Aug, 2021
(3 years ago)
Expired
US6988496 Cartridge for a liquid 23 Feb, 2020
(4 years ago)
Expired
US7802568 Cartridge for a liquid 26 Feb, 2019
(5 years ago)
Expired
US6846413 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6977042 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6149054 Mechanical counter for a metering apparatus 19 Dec, 2016
(7 years ago)
Expired
US6453795 Locking mechanism for a spring-actuated device 05 Dec, 2016
(7 years ago)
Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 04 Oct, 2016
(8 years ago)
Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7246615 Atomising nozzle and filter and spray generating device 31 May, 2016
(8 years ago)
Expired
US5662271 Atomizing devices and methods 02 Sep, 2014
(10 years ago)
Expired
US5472143 Atomising nozzle and filter and spray generation device 29 Sep, 2013
(11 years ago)
Expired
US5911851 Atomizing nozzle and filter and spray generating device 29 Sep, 2013
(11 years ago)
Expired
US6007676 Atomizing nozzle and filter and spray generating device 29 Sep, 2013
(11 years ago)
Expired
US6503362 Atomizing nozzle an filter and spray generating device 29 Sep, 2013
(11 years ago)
Expired
US5497944 Atomising devices and methods 12 Mar, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combivent Respimat's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Gilotrif

Gilotrif is protected by 11 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10004743
(Pediatric)
Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient 05 Jan, 2031
(6 years from now)
Active
US10004743 Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient 05 Jul, 2030
(5 years from now)
Active
US8545884
(Pediatric)
Solid pharmaceutical formulations comprising BIBW 2992 19 Jun, 2030
(5 years from now)
Active
US8426586
(Pediatric)
Process for preparing amino crotonyl compounds 10 Apr, 2030
(5 years from now)
Active
US8545884 Solid pharmaceutical formulations comprising BIBW 2992 19 Dec, 2029
(5 years from now)
Active
US8426586 Process for preparing amino crotonyl compounds 10 Oct, 2029
(5 years from now)
Active
US9539258
(Pediatric)
Quinazoline derivatives for the treatment of cancer diseases 09 May, 2027
(2 years from now)
Active
US9539258 Quinazoline derivatives for the treatment of cancer diseases 09 Nov, 2026
(2 years from now)
Active
USRE43431
(Pediatric)
Quinazoline derivatives and pharmaceutical compositions containing them 13 Jul, 2026
(1 year, 9 months from now)
Active
USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them 13 Jan, 2026
(1 year, 3 months from now)
Active
US6251912 Substituted quinazoline derivatives 29 Jul, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gilotrif's drug page


7. Glyxambi

Glyxambi is protected by 29 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10258637
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US11090323
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Jun, 2034
(9 years from now)
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US10406172 Pharmaceutical composition, methods for treating and uses thereof 15 Jun, 2030
(5 years from now)
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Jun, 2030
(5 years from now)
Active
US8551957
(Pediatric)
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Apr, 2030
(5 years from now)
Active
US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Oct, 2029
(5 years from now)
Active
US7579449
(Pediatric)
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
(4 years from now)
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
(3 years from now)
Active
US11033552
(Pediatric)
DPP IV inhibitor formulations 04 Nov, 2027
(3 years from now)
Active
US8673927
(Pediatric)
Uses of DPP-IV inhibitors 04 Nov, 2027
(3 years from now)
Active
US7713938
(Pediatric)
Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
(3 years from now)
Active
US11033552 DPP IV inhibitor formulations 04 May, 2027
(2 years from now)
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
(2 years from now)
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
(2 years from now)
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
(2 years from now)
Active
US8883805
(Pediatric)
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
(1 year, 7 months from now)
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
(1 year, 1 month from now)
Active
US7407955
(Pediatric)
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
(1 year, 27 days from now)
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
(6 months from now)
Active
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US6890898 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7078381 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7459428 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals 24 Apr, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Glyxambi's drug page


8. Jardiance

Jardiance is protected by 18 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9949998
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 11 Dec, 2034
(10 years from now)
Active
US9949997
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 17 Nov, 2034
(10 years from now)
Active
US10258637
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US11090323
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Jun, 2034
(9 years from now)
Active
US9949997 Pharmaceutical composition, methods for treating and uses thereof 17 May, 2034
(9 years from now)
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11666590 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11813275 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US10406172 Pharmaceutical composition, methods for treating and uses thereof 15 Jun, 2030
(5 years from now)
Active
US8551957
(Pediatric)
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Apr, 2030
(5 years from now)
Active
US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Oct, 2029
(5 years from now)
Active
US7579449
(Pediatric)
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
(4 years from now)
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
(3 years from now)
Active
US7713938
(Pediatric)
Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
(3 years from now)
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jardiance's drug page


9. Jentadueto

Jentadueto is protected by 24 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8846695
(Pediatric)
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Dec, 2030
(6 years from now)
Active
US9155705
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 Nov, 2030
(6 years from now)
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Jun, 2030
(5 years from now)
Active
US9155705 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 May, 2030
(5 years from now)
Active
US11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug 10 Apr, 2030
(5 years from now)
Active
US10022379
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
(4 years from now)
Active
US10973827
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
(4 years from now)
Active
US9415016
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
(4 years from now)
Active
US10022379 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US9415016 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US8673927
(Pediatric)
Uses of DPP-IV inhibitors 04 Nov, 2027
(3 years from now)
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
(2 years from now)
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
(2 years from now)
Active
US8883805
(Pediatric)
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
(1 year, 7 months from now)
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
(1 year, 1 month from now)
Active
US7407955
(Pediatric)
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
(1 year, 27 days from now)
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
(6 months from now)
Active
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US6890898 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7078381 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7459428 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals 24 Apr, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jentadueto's drug page


10. Jentadueto Xr

Jentadueto Xr is protected by 27 patents, out of which 9 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9555001
(Pediatric)
Pharmaceutical composition and uses thereof 06 Sep, 2033
(8 years from now)
Active
US9555001 Pharmaceutical composition and uses thereof 06 Mar, 2033
(8 years from now)
Active
US9155705
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 Nov, 2030
(6 years from now)
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Jun, 2030
(5 years from now)
Active
US9155705 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 May, 2030
(5 years from now)
Active
US11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug 10 Apr, 2030
(5 years from now)
Active
US10022379
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
(4 years from now)
Active
US9415016
(Pediatric)
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Oct, 2029
(4 years from now)
Active
US10022379 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US9415016 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US8673927
(Pediatric)
Uses of DPP-IV inhibitors 04 Nov, 2027
(3 years from now)
Active
US9173859
(Pediatric)
Uses of DPP IV inhibitors 04 Nov, 2027
(3 years from now)
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
(2 years from now)
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
(2 years from now)
Active
US8883805
(Pediatric)
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
(1 year, 7 months from now)
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
(1 year, 1 month from now)
Active
US7407955
(Pediatric)
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
(1 year, 27 days from now)
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
(6 months from now)
Active
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US6488962 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms 20 Jun, 2020
(4 years ago)
Expired
US6890898 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7078381 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7459428 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals 24 Apr, 2017
(7 years ago)
Expired
US6340475 Extending the duration of drug release within the stomach during the fed mode 19 Sep, 2016
(8 years ago)
Expired
US6635280 Extending the duration of drug release within the stomach during the fed mode 19 Sep, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jentadueto Xr's drug page


11. Micardis

Micardis is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8003679 Use of inhibitors of the renin-angiotensin system 06 Oct, 2022
(2 years ago)
Expired
US7998953 Use of inhibitors of the renin-angiotensin system 06 Jun, 2020
(4 years ago)
Expired
US6358986 Polymorphs of telmisartan 10 Jan, 2020
(4 years ago)
Expired
US5591762 Benzimidazoles useful as angiotensin-11 antagonists 07 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Micardis's drug page


12. Micardis Hct

Micardis Hct is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6358986 Polymorphs of telmisartan 10 Jan, 2020
(4 years ago)
Expired
US5591762 Benzimidazoles useful as angiotensin-11 antagonists 07 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Micardis Hct's drug page


13. Mirapex

Mirapex is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6001861 Use of pramipexole in the treatment of restless legs syndrome 16 Jan, 2018
(6 years ago)
Expired
US6194445 Use of pramipexole in the treatment of restless legs syndrome 16 Jan, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mirapex's drug page


14. Mirapex Er

Mirapex Er is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8679533 Pramipexole once-daily dosage form 08 Sep, 2029
(4 years from now)
Active
US7695734 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof 26 Apr, 2028
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mirapex Er's drug page


15. Ofev

Ofev is protected by 10 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9907756
(Pediatric)
Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative 07 Dec, 2029
(5 years from now)
Active
US10105323
(Pediatric)
Pharmaceutical dosage form for immediate release of an indolinone derivative 04 Dec, 2029
(5 years from now)
Active
US9907756 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative 07 Jun, 2029
(4 years from now)
Active
US10105323 Pharmaceutical dosage form for immediate release of an indolinone derivative 04 Jun, 2029
(4 years from now)
Active
US10154990
(Pediatric)
Medicaments for the treatment or prevention of fibrotic diseases 08 Jul, 2026
(1 year, 9 months from now)
Active
US6762180
(Pediatric)
Substituted indolines which inhibit receptor tyrosine kinases 01 Apr, 2026
(1 year, 5 months from now)
Active
US10154990 Medicaments for the treatment or prevention of fibrotic diseases 08 Jan, 2026
(1 year, 3 months from now)
Active
US6762180 Substituted indolines which inhibit receptor tyrosine kinases 01 Oct, 2025
(11 months from now)
Active
US7989474 Use of Lck inhibitors for treatment of immunologic diseases 06 Apr, 2024
(5 months ago)
Expired
US7119093 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition 21 Feb, 2024
(7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ofev's drug page


16. Pradaxa

Pradaxa is protected by 11 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9034822
(Pediatric)
Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 20 Jul, 2031
(6 years from now)
Active
US9034822 Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 20 Jan, 2031
(6 years from now)
Active
US7866474
(Pediatric)
Film container 02 Mar, 2028
(3 years from now)
Active
US7866474 Film container 31 Aug, 2027
(2 years from now)
Active
US7932273
(Pediatric)
3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament 07 Mar, 2026
(1 year, 4 months from now)
Active
US7932273 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament 07 Sep, 2025
(11 months from now)
Active
US9925174
(Pediatric)
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof 14 Dec, 2023
(9 months ago)
Expired
US9925174 Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-methyl-1 H-benzimidazol acid ethyl ester and the salts thereof 14 Jun, 2023
(1 year, 3 months ago)
Expired
US6087380
(Pediatric)
Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions 28 Jun, 2022
(2 years ago)
Expired
US6087380 Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions 28 Dec, 2021
(2 years ago)
Expired
US6087380 Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions 18 Feb, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pradaxa's drug page


17. Spiriva

Spiriva is protected by 20 patents, out of which 15 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9010323 Inhaler and sieve for an inhaler 19 Apr, 2030
(5 years from now)
Active
US7694676
(Pediatric)
Dry powder inhaler 12 Sep, 2027
(2 years from now)
Active
US7694676 Dry powder inhaler 12 Mar, 2027
(2 years from now)
Active
US8022082
(Pediatric)
Method for the administration of an anticholinergic by inhalation 19 Jul, 2026
(1 year, 9 months from now)
Active
US8022082 Method for the administration of an anticholinergic by inhalation 19 Jan, 2026
(1 year, 3 months from now)
Active
US7070800
(Pediatric)
Inhalable powder containing tiotropium 22 Jul, 2022
(2 years ago)
Expired
USRE38912
(Pediatric)
Process for preparing powder formulations 11 Apr, 2022
(2 years ago)
Expired
US6777423
(Pediatric)
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Mar, 2022
(2 years ago)
Expired
US6908928
(Pediatric)
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Mar, 2022
(2 years ago)
Expired
US7309707
(Pediatric)
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Mar, 2022
(2 years ago)
Expired
US7642268
(Pediatric)
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Mar, 2022
(2 years ago)
Expired
US7070800 Inhalable powder containing tiotropium 22 Jan, 2022
(2 years ago)
Expired
USRE38912 Process for preparing powder formulations 11 Oct, 2021
(2 years ago)
Expired
US6777423 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Sep, 2021
(3 years ago)
Expired
US6908928 Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions 24 Sep, 2021
(3 years ago)
Expired
US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Sep, 2021
(3 years ago)
Expired
US7642268 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament 24 Sep, 2021
(3 years ago)
Expired
USRE39820
(Pediatric)
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jul, 2018
(6 years ago)
Expired
USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jan, 2018
(6 years ago)
Expired
US5478578 Powders for inhalation 26 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Spiriva's drug page


18. Spiriva Respimat

Spiriva Respimat is protected by 39 patents, out of which 28 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8733341
(Pediatric)
Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Apr, 2031
(6 years from now)
Active
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Oct, 2030
(6 years from now)
Active
US7837235
(Pediatric)
Device for clamping a fluidic component 13 Sep, 2028
(3 years from now)
Active
US7837235 Device for clamping a fluidic component 13 Mar, 2028
(3 years from now)
Active
US9027967
(Pediatric)
Device for clamping a fluidic component 01 Oct, 2027
(2 years from now)
Active
US7396341
(Pediatric)
Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Apr, 2027
(2 years from now)
Active
US9027967 Device for clamping a fluidic component 31 Mar, 2027
(2 years from now)
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Oct, 2026
(2 years from now)
Active
US7896264
(Pediatric)
Microstructured high pressure nozzle with built-in filter function 26 Nov, 2025
(1 year, 1 month from now)
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 May, 2025
(7 months from now)
Active
US7284474
(Pediatric)
Piston-pumping system having o-ring seal properties 26 Feb, 2025
(4 months from now)
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Aug, 2024
(a month ago)
Expired
US7988001
(Pediatric)
Container provided with a pressure equalization opening 04 Feb, 2022
(2 years ago)
Expired
US7988001 Container provided with a pressure equalization opening 04 Aug, 2021
(3 years ago)
Expired
US6988496
(Pediatric)
Cartridge for a liquid 23 Aug, 2020
(4 years ago)
Expired
US6988496 Cartridge for a liquid 23 Feb, 2020
(4 years ago)
Expired
US7802568
(Pediatric)
Cartridge for a liquid 26 Aug, 2019
(5 years ago)
Expired
US6846413
(Pediatric)
Microstructured filter 28 Feb, 2019
(5 years ago)
Expired
US6977042
(Pediatric)
Microstructured filter 28 Feb, 2019
(5 years ago)
Expired
US7802568 Cartridge for a liquid 26 Feb, 2019
(5 years ago)
Expired
US6846413 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6977042 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
USRE39820
(Pediatric)
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jul, 2018
(6 years ago)
Expired
USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jan, 2018
(6 years ago)
Expired
US6149054
(Pediatric)
Mechanical counter for a metering apparatus 16 Jun, 2017
(7 years ago)
Expired
US6453795
(Pediatric)
Locking mechanism for a spring-actuated device 05 Jun, 2017
(7 years ago)
Expired
US5964416
(Pediatric)
Device for producing high pressure in a fluid in miniature 04 Apr, 2017
(7 years ago)
Expired
US6726124
(Pediatric)
Device for producing high pressure in a fluid in miniature 04 Apr, 2017
(7 years ago)
Expired
US7104470
(Pediatric)
Device for producing high pressure in a fluid in miniature 04 Apr, 2017
(7 years ago)
Expired
US6149054 Mechanical counter for a metering apparatus 16 Dec, 2016
(7 years ago)
Expired
US6453795 Locking mechanism for a spring-actuated device 05 Dec, 2016
(7 years ago)
Expired
US6176442
(Pediatric)
Device for mounting a component exposed to a pressurized fluid 01 Dec, 2016
(7 years ago)
Expired
US7246615
(Pediatric)
Atomising nozzle and filter and spray generating device 01 Dec, 2016
(7 years ago)
Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US6176242 Method of treating manic depression by brain infusion 31 May, 2016
(8 years ago)
Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 31 May, 2016
(8 years ago)
Expired
US7246615 Atomising nozzle and filter and spray generating device 31 May, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Spiriva Respimat's drug page


19. Stiolto Respimat

Stiolto Respimat is protected by 34 patents, out of which 23 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Oct, 2030
(6 years from now)
Active
US7837235
(Pediatric)
Device for clamping a fluidic component 13 Sep, 2028
(3 years from now)
Active
US7837235 Device for clamping a fluidic component 13 Mar, 2028
(3 years from now)
Active
US7396341
(Pediatric)
Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Apr, 2027
(2 years from now)
Active
US9027967 Device for clamping a fluidic component 31 Mar, 2027
(2 years from now)
Active
US7727984 Medicaments for the treatment of chronic obstructive pulmonary disease 19 Jan, 2027
(2 years from now)
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Oct, 2026
(2 years from now)
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 May, 2025
(7 months from now)
Active
US7220742 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
(7 months from now)
Active
US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
(7 months from now)
Active
US7284474
(Pediatric)
Piston-pumping system having o-ring seal properties 26 Feb, 2025
(4 months from now)
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Aug, 2024
(a month ago)
Expired
US7056916 Medicaments for the treatment of chronic obstructive pulmonary disease 07 Dec, 2023
(9 months ago)
Expired
US7491719 Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments 10 Nov, 2023
(10 months ago)
Expired
US7786111 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023
(10 months ago)
Expired
US8044046 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023
(10 months ago)
Expired
US7988001 Container provided with a pressure equalization opening 04 Aug, 2021
(3 years ago)
Expired
US6988496
(Pediatric)
Cartridge for a liquid 23 Aug, 2020
(4 years ago)
Expired
US6988496 Cartridge for a liquid 23 Feb, 2020
(4 years ago)
Expired
US7802568
(Pediatric)
Cartridge for a liquid 26 Aug, 2019
(5 years ago)
Expired
US6846413
(Pediatric)
Microstructured filter 28 Feb, 2019
(5 years ago)
Expired
US6977042
(Pediatric)
Microstructured filter 28 Feb, 2019
(5 years ago)
Expired
US7802568 Cartridge for a liquid 26 Feb, 2019
(5 years ago)
Expired
US6846413 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6977042 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products 30 Jan, 2018
(6 years ago)
Expired
US6149054
(Pediatric)
Mechanical counter for a metering apparatus 19 Jun, 2017
(7 years ago)
Expired
US6149054 Mechanical counter for a metering apparatus 19 Dec, 2016
(7 years ago)
Expired
US6453795 Locking mechanism for a spring-actuated device 05 Dec, 2016
(7 years ago)
Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 04 Oct, 2016
(8 years ago)
Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7246615 Atomising nozzle and filter and spray generating device 31 May, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stiolto Respimat's drug page


20. Striverdi Respimat

Striverdi Respimat is protected by 25 patents, out of which 17 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8733341 Atomizer and method of atomizing fluid with a nozzle rinsing mechanism 16 Oct, 2030
(6 years from now)
Active
US7837235 Device for clamping a fluidic component 13 Mar, 2028
(3 years from now)
Active
US9027967 Device for clamping a fluidic component 31 Mar, 2027
(2 years from now)
Active
US7727984 Medicaments for the treatment of chronic obstructive pulmonary disease 19 Jan, 2027
(2 years from now)
Active
US7396341 Blocking device for a locking stressing mechanism having a spring-actuated output drive device 10 Oct, 2026
(2 years from now)
Active
US7896264 Microstructured high pressure nozzle with built-in filter function 26 May, 2025
(7 months from now)
Active
US7220742 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
(7 months from now)
Active
US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments 12 May, 2025
(7 months from now)
Active
US7284474 Piston-pumping system having o-ring seal properties 26 Aug, 2024
(a month ago)
Expired
US7056916 Medicaments for the treatment of chronic obstructive pulmonary disease 07 Dec, 2023
(9 months ago)
Expired
US7491719 Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments 10 Nov, 2023
(10 months ago)
Expired
US7786111 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023
(10 months ago)
Expired
US8044046 Medicaments for the treatment of chronic obstructive pulmonary disease 10 Nov, 2023
(10 months ago)
Expired
US7988001 Container provided with a pressure equalization opening 04 Aug, 2021
(3 years ago)
Expired
US6988496 Cartridge for a liquid 23 Feb, 2020
(4 years ago)
Expired
US7802568 Cartridge for a liquid 26 Feb, 2019
(5 years ago)
Expired
US6846413 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6977042 Microstructured filter 28 Aug, 2018
(6 years ago)
Expired
US6149054 Mechanical counter for a metering apparatus 19 Dec, 2016
(7 years ago)
Expired
US6453795 Locking mechanism for a spring-actuated device 05 Dec, 2016
(7 years ago)
Expired
US5964416 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US6176442 Device for mounting a component exposed to a pressurized fluid 04 Oct, 2016
(8 years ago)
Expired
US6726124 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7104470 Device for producing high pressure in a fluid in miniature 04 Oct, 2016
(8 years ago)
Expired
US7246615 Atomising nozzle and filter and spray generating device 31 May, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Striverdi Respimat's drug page


21. Synjardy

Synjardy is protected by 14 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9949997
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 17 Nov, 2034
(10 years from now)
Active
US10258637
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US11090323
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US9949997 Pharmaceutical composition, methods for treating and uses thereof 17 May, 2034
(9 years from now)
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11813275 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US10610489
(Pediatric)
Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof 30 Mar, 2031
(6 years from now)
Active
US10610489 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof 30 Sep, 2030
(5 years from now)
Active
US7579449
(Pediatric)
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
(4 years from now)
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
(3 years from now)
Active
US7713938
(Pediatric)
Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
(3 years from now)
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Synjardy's drug page


22. Synjardy Xr

Synjardy Xr is protected by 17 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9949998
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 11 Dec, 2034
(10 years from now)
Active
US9949997
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 17 Nov, 2034
(10 years from now)
Active
US10258637
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US11090323
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Jun, 2034
(9 years from now)
Active
US9949997 Pharmaceutical composition, methods for treating and uses thereof 17 May, 2034
(9 years from now)
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11813275 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US10596120
(Pediatric)
Pharmaceutical compositions 07 Sep, 2032
(7 years from now)
Active
US10596120 Pharmaceutical compositions 07 Mar, 2032
(7 years from now)
Active
US7579449
(Pediatric)
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
(4 years from now)
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
(3 years from now)
Active
US7713938
(Pediatric)
Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
(3 years from now)
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
(2 years from now)
Active
US6488962 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms 20 Jun, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Synjardy Xr's drug page


23. Tradjenta

Tradjenta is protected by 24 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8853156
(Pediatric)
Treatment for diabetes in patients inappropriate for metformin therapy 05 Sep, 2031
(6 years from now)
Active
US8853156 Treatment for diabetes in patients inappropriate for metformin therapy 05 Mar, 2031
(6 years from now)
Active
US8846695
(Pediatric)
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Dec, 2030
(6 years from now)
Active
US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor 04 Jun, 2030
(5 years from now)
Active
US11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug 10 Apr, 2030
(5 years from now)
Active
US10034877
(Pediatric)
Treatment for diabetes in patients inappropriate for metformin therapy 05 Feb, 2030
(5 years from now)
Active
US9486526
(Pediatric)
Treatment for diabetes in patients inappropriate for metformin therapy 05 Feb, 2030
(5 years from now)
Active
US10034877 Treatment for diabetes in patients inappropriate for metformin therapy 05 Aug, 2029
(4 years from now)
Active
US9486526 Treatment for diabetes in patients inappropriate for metformin therapy 05 Aug, 2029
(4 years from now)
Active
US11033552
(Pediatric)
DPP IV inhibitor formulations 04 Nov, 2027
(3 years from now)
Active
US8673927
(Pediatric)
Uses of DPP-IV inhibitors 04 Nov, 2027
(3 years from now)
Active
US11033552 DPP IV inhibitor formulations 04 May, 2027
(2 years from now)
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
(2 years from now)
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
(2 years from now)
Active
US8883805
(Pediatric)
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
(1 year, 7 months from now)
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
(1 year, 1 month from now)
Active
US7407955
(Pediatric)
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
(1 year, 27 days from now)
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
(6 months from now)
Active
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US6890898 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7078381 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US7459428 Method of regulating glucose metabolism, and reagents related thereto 02 Feb, 2019
(5 years ago)
Expired
US6303661 Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals 24 Apr, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tradjenta's drug page


24. Trijardy Xr

Trijardy Xr is protected by 28 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9949998
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 11 Dec, 2034
(10 years from now)
Active
US10258637
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US11090323
(Pediatric)
Pharmaceutical composition, methods for treating and uses thereof 03 Oct, 2034
(9 years from now)
Active
US9949998 Pharmaceutical composition, methods for treating and uses thereof 11 Jun, 2034
(9 years from now)
Active
US10258637 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11090323 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US11833166 Pharmaceutical composition, methods for treating and uses thereof 03 Apr, 2034
(9 years from now)
Active
US10596120 Pharmaceutical compositions 07 Mar, 2032
(7 years from now)
Active
US11564886 Pharmaceutical compositions 07 Mar, 2032
(7 years from now)
Active
US10406172 Pharmaceutical composition, methods for treating and uses thereof 15 Jun, 2030
(5 years from now)
Active
US9155705 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 21 May, 2030
(5 years from now)
Active
US8551957
(Pediatric)
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Apr, 2030
(5 years from now)
Active
US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate 14 Oct, 2029
(5 years from now)
Active
US10022379 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US9415016 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation 02 Apr, 2029
(4 years from now)
Active
US7579449
(Pediatric)
Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Feb, 2029
(4 years from now)
Active
US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture 01 Aug, 2028
(3 years from now)
Active
US7713938
(Pediatric)
Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Oct, 2027
(3 years from now)
Active
US8673927 Uses of DPP-IV inhibitors 04 May, 2027
(2 years from now)
Active
US9173859 Uses of DPP IV inhibitors 04 May, 2027
(2 years from now)
Active
US7713938 Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments 15 Apr, 2027
(2 years from now)
Active
US8883805
(Pediatric)
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 May, 2026
(1 year, 7 months from now)
Active
US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines 26 Nov, 2025
(1 year, 1 month from now)
Active
US7407955
(Pediatric)
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 Nov, 2025
(1 year, 27 days from now)
Active
US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 02 May, 2025
(6 months from now)
Active
US8119648 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions 12 Aug, 2023
(1 year, 1 month ago)
Expired
US6488962 Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms 20 Jun, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Trijardy Xr's drug page


25. Twynsta

Twynsta is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5591762 Benzimidazoles useful as angiotensin-11 antagonists 07 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Twynsta's drug page


26. Viramune Xr

Viramune Xr is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8460704 Extended release formulation of nevirapine 12 Mar, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viramune Xr's drug page